Lord, Abbett & Co »

Ascendis Pharma AS shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $39M 145k 266.72

More positions owned by Lord, Abbett & Co

NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Lam Research (LRCX)
Broadcom (AVGO)
Taiwan Semiconductor Mfg (TSM)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Morgan Stanley (MS)
Comfort Systems USA (FIX)
UnitedHealth (UNH)
Analog Devices (ADI)
Parker-Hannifin Corporation (PH)
Johnson & Johnson (JNJ)

View all positions for Lord, Abbett & Co

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS